Phase I clinical trial - Appareil pulmonaire

Appareil pulmonaire
Ouvert depuis le: 10.24.2020
Site: Paris
Public cible
A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer
Description de l'essai

The purpose of this study is to determine the recommended phase 2 dose of LY3295668 erbumine in participants with platinum-sensitive, extensive-stage small-cell lung cancer.